Medicare reverses billing change on Genentech drug

Medicare to pay for $93,000 prostate cancer drug
WASHINGTON (AP) -- Medicare officials said Wednesday that the program will pay the $93,000 cost of prostate cancer drug Provenge, an innovative therapy that gives men suffering from the...

Dendreon trades higher on prostate drug review
WASHINGTON (AP) -- Shares of biotech drugmaker Dendreon jumped Thursday after Medicare officials issued a mostly positive assessment of the company's prostate cancer therapy, setting the...

The Real Issues of End-of-Life Care
Beyond the hyperventilating about euthanasia and death panels, how Medicare works with end-of-life care is a real issue for doctors who deal with the elderly, like geriatrician Dr. Laurie...

Burt's Bees Free Head to Toe Starter Kit

Lobe Wonder Ear Support Patches For Earrings,...